NMRA · NASDAQ · Biotechnology

Neumora Therapeutics (NMRA)

Develops precision medicines for brain diseases using neuroscience and data science.

$1.38
At close+0.04 (+3.38%)

Something off on this page? Send us feedback.

Next report
Nov 5, 2026
in 63 days
EPS estimate
−$0.19
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.42−$0.33−$0.35−$0.35−$0.30−$0.23−$0.23Pending
Estimate−$0.40−$0.38−$0.34−$0.34−$0.32−$0.24−$0.24−$0.19
Surprise−5.0%+13.2%−2.9%−2.9%+6.3%+4.2%+4.2%

RevenueReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
ReportedPending
Estimate
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$0.19
Aug 2026−$0.24−$0.23+4.2%
Aug 2026−$0.24−$0.23+4.2%
May 2026−$0.32−$0.30+6.3%
Mar 2026−$0.34−$0.35−2.9%

The latest year is open to everyone — the 20 quarters behind it read with an account.

Sign in
Nov 2025
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Mar 2021
Dec 2020
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 5, 2026−$0.19
Aug 14, 2026−$0.24−$0.23+4.2%−7.5%
Aug 13, 2026−$0.24−$0.23+4.2%+1.2%
May 7, 2026−$0.32−$0.30+6.3%−5.7%
Mar 16, 2026−$0.34−$0.35−2.9%−1.4%

The latest year is open to everyone — the 20 quarters behind it read with an account.

Sign in
Nov 6, 2025
Aug 6, 2025
May 12, 2025
Mar 3, 2025
Nov 12, 2024
Aug 6, 2024
May 7, 2024
Mar 7, 2024
Nov 1, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020